SABBY 13G OXBT 04.18.13

Company

Oncotelic Therapeutics, Inc.

Filed

April 18, 2013

Accession Number

0001535610-13-000034

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →